Form 4 filed by Barlow Carrolee
Barlow Carrolee filed this Form 4 on SUPN (SUPERNUS PHARMACEUTICALS, INC.) with 11 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-04 21:33:59 UTC.
- Accession
- 0001745316-26-000006
- Filer
- CIK 1745316
- Filed
- 2026-11-04
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: SUPN · SUPERNUS PHARMACEUTICALS, INC. (CIK 1356576)
- Barlow Carrolee director
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-02 | J other | -27,045 | $0 | 0 | D |
| Restricted Stock Unit derivative | 2026-11-02 | J other | -2,989 | $0 | 0 | D |
| Director Stock Option (Right to Buy) derivative | 2026-11-02 | J other | -10,213 | $0 | 0 | D |
| Director Stock Option (Right to Buy) derivative | 2026-11-02 | J other | -12,427 | $0 | 0 | D |
| Director Stock Option (Right to Buy) derivative | 2026-11-02 | J other | -9,305 | $0 | 0 | D |
| Director Stock Option (Right to Buy) derivative | 2026-11-02 | J other | -7,365 | $0 | 0 | D |
| Director Stock Option (Right to Buy) derivative | 2026-11-02 | J other | -6,847 | $0 | 0 | D |
| Director Stock Option (Right to Buy) derivative | 2026-11-02 | J other | -6,293 | $0 | 0 | D |
| Director Stock Option (Right to Buy) derivative | 2026-11-02 | J other | -8,252 | $0 | 0 | D |
| Director Stock Option (Right to Buy) derivative | 2026-11-02 | J other | -7,296 | $0 | 0 | D |
| Director Stock Option (Right to Buy) derivative | 2026-11-02 | J other | -4,977 | $0 | 0 | D |